Find your next paid study

Alliance for Clinical Trials in OncologyNCT07293247

~$75 – $2,000

Actual pay is set by the research site.

Personalized Risk Assessment of Seizures Sensitive to Poor Sleep: a Longitudinal Study Using Wearable Electroencephalography Devices

Epilepsy, a prevalent neurological disorder, affects 40% of patients with uncontrolled seizures despite medications. Sleep disturbance exacerbates epilepsy, an…

Epilepsy Intractable

Duke UniversityNCT06545643

Actual pay is set by the research site.

Evaluation of a Lupus Nephritis Care Pathway Integrating Telemedicine and Clinical Pharmacist Practitioners

The purpose of this study is to evaluate an approach to managing patients with lupus nephritis called the Lupus Nephritis (LN) Pathway among approximately 25 p…

Lupus Nephritis (LN)

Duke UniversityNCT07783152

Actual pay is set by the research site.

Perinatal AnxietyPerinatal Depression

Improving Perinatal Mental Health Among Latinas Through a Culturally Adapted, Multi-Level Intervention

The goal of this clinical trial is to learn if an intervention can improve mental health outcomes among pregnant and postpartum Latinas. The main questions it …

American UniversityNCT07880457

Actual pay is set by the research site.

Phase 1

A Phase 1/2 Open-label First-in-Human Dose-Escalating Safety and Efficacy Study Evaluating Subcutaneous Administration of PTH-IA in Adults and Children With Jansen s Metaphyseal Chondrodysplasia (JMC)

Jansen s Metaphyseal Chondrodysplasia (JMC) is a very rare disorder with only approximately 30 people known to have the disease worldwide. It is caused by para…

Jansen's Metaphyseal Chondrodysplasia

National Institute of Dental and Craniofacial Research (NIDCR)NCT07541209

~$150 – $2,700

Actual pay is set by the research site.

Phase 2

A Parallel-group Treatment, Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Umbrella Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, and Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)

This is a parallel, Phase 2a, double-blind, 6-arm study for the treatment of primary focal segmental glomerulosclerosis (FSGS) or minimal change disease (MCD).…

Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion

Alzheimer's Disease Psychosis

~$75 – $3,000

Actual pay is set by the research site.

SanofiNCT06500702

Phase 2

A Master Protocol for Three Independent, Seamlessly Enrolling, Double-blind, Placebo-controlled Efficacy and Safety Studies of ACP-204 in Adults With Alzheimer's Disease Psychosis

This is a master protocol for 3 independent, seamlessly enrolling, multicenter, randomized, double-blind, placebo-controlled, parallel-group studies in patient…

ACADIA Pharmaceuticals Inc.NCT06159673

~$75 – $2,800

Actual pay is set by the research site.

Accelerated Resolution Therapy for Early Maladaptive Grief: A Clinical Trial

The purpose study is to test the effects of accelerated resolution therapy (ART) on pre-loss grief and prolonged grief disorder among older adult family caregi…

Grief

Head and Neck CancerHead and Neck Squamous Cell CarcinomaMetastatic Head and Neck Cancer+3 more

Actual pay is set by the research site.

Mayo ClinicNCT05624879

Phase 2

A Phase 2 Trial of PD-L1 t-haNK, NAI IL-15 Superagonist (Anktiva), and Cetuximab for Immunotherapy-treated Patients With Recurrent, Metastatic HNSCC (QUILT-505)

The purpose of this research study is to test the safety and efficacy of the combination of PD-L1 t-haNK (modified immune cells), NAI (a manufactured protein t…

Dana-Farber Cancer InstituteNCT06239220

~$75 – $3,000

Actual pay is set by the research site.

Phase 1

Pilot Study of Asciminib as a Maintenance Treatment Post Cellular Therapies in Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

This phase I trial tests the safety, side effects and best dose of asciminib as maintenance treatment for adults with Philadelphia chromosome positive acute ly…

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

City of Hope Medical CenterNCT07040982

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

A Phase 1b Study of Safety, Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis)

The purpose of this clinical trial is to learn if the study drug ropeginterferon alfa- 2b added to, standard of care, ruxolitinib is safe and effective in trea…

Myelofibrosis

University of UtahNCT07521046

~$150 – $3,000

Actual pay is set by the research site.

Phase 3

A Phase 3, Multicenter, Prospective Open-Label Study of the Diagnostic Performance of [¹⁸F]FAPI-74 PET/CT for the Detection of Metastatic Disease in Adults With Pancreatic Ductal Adenocarcinoma

This is a multi-site, open-label, non-randomized, single dose study to assess the clinical utility of \[¹⁸F\]FAPI-74 PET/CT in the detection of metastatic dise…

Pancreatic Ductal Adenocarcinoma (PDAC)